These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28867783)

  • 1. The Mouse Papillomavirus Infection Model.
    Hu J; Cladel NM; Budgeon LR; Balogh KK; Christensen ND
    Viruses; 2017 Aug; 9(9):. PubMed ID: 28867783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer.
    Cladel NM; Budgeon LR; Balogh KK; Cooper TK; Brendle SA; Christensen ND; Schell TD; Hu J
    Sci Rep; 2017 Dec; 7(1):16932. PubMed ID: 29208932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).
    Uberoi A; Yoshida S; Lambert PF
    J Virol Methods; 2018 Mar; 253():11-17. PubMed ID: 29253496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to commensal papillomaviruses protects against skin cancer.
    Strickley JD; Messerschmidt JL; Awad ME; Li T; Hasegawa T; Ha DT; Nabeta HW; Bevins PA; Ngo KH; Asgari MM; Nazarian RM; Neel VA; Jenson AB; Joh J; Demehri S
    Nature; 2019 Nov; 575(7783):519-522. PubMed ID: 31666702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
    Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in preclinical model systems for papillomaviruses.
    Christensen ND; Budgeon LR; Cladel NM; Hu J
    Virus Res; 2017 Mar; 231():108-118. PubMed ID: 27956145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel
    Spurgeon ME; Uberoi A; McGregor SM; Wei T; Ward-Shaw E; Lambert PF
    mBio; 2019 Mar; 10(2):. PubMed ID: 30837335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell-mediated antitumor immune response eliminates skin tumors induced by mouse papillomavirus, MmuPV1.
    Joh J; Chilton PM; Wilcher SA; Zahin M; Park J; Proctor ML; Ghim SJ; Jenson AB
    Exp Mol Pathol; 2017 Oct; 103(2):181-190. PubMed ID: 28939161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.
    Scagnolari C; Cannella F; Pierangeli A; Mellinger Pilgrim R; Antonelli G; Rowley D; Wong M; Best S; Xing D; Roden RBS; Viscidi R
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary infections, expanded tissue tropism, and evidence for malignant potential in immunocompromised mice infected with Mus musculus papillomavirus 1 DNA and virus.
    Cladel NM; Budgeon LR; Cooper TK; Balogh KK; Hu J; Christensen ND
    J Virol; 2013 Aug; 87(16):9391-5. PubMed ID: 23785210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas.
    Sundberg JP; Stearns TM; Joh J; Proctor M; Ingle A; Silva KA; Dadras SS; Jenson AB; Ghim SJ
    PLoS One; 2014; 9(12):e113582. PubMed ID: 25474466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Ultraviolet Radiation in Papillomavirus-Induced Disease.
    Uberoi A; Yoshida S; Frazer IH; Pitot HC; Lambert PF
    PLoS Pathog; 2016 May; 12(5):e1005664. PubMed ID: 27244228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host defence and persistent human papillomavirus infection.
    Stanley M
    Curr Opin Virol; 2021 Dec; 51():106-110. PubMed ID: 34628358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues.
    Xue XY; Majerciak V; Uberoi A; Kim BH; Gotte D; Chen X; Cam M; Lambert PF; Zheng ZM
    PLoS Pathog; 2017 Nov; 13(11):e1006715. PubMed ID: 29176795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse model of cervicovaginal papillomavirus infection.
    Çuburu N; Cerio RJ; Thompson CD; Day PM
    Methods Mol Biol; 2015; 1249():365-79. PubMed ID: 25348320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MmuPV1 infection and tumor development of T cell-deficient mice is prevented by passively transferred hyperimmune sera from normal congenic mice immunized with MmuPV1 virus-like particles (VLPs).
    Joh J; Ghim SJ; Chilton PM; Sundberg JP; Park J; Wilcher SA; Proctor ML; Bennett Jenson A
    Exp Mol Pathol; 2016 Feb; 100(1):212-9. PubMed ID: 26778691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.
    Handisurya A; Day PM; Thompson CD; Buck CB; Kwak K; Roden RB; Lowy DR; Schiller JT
    Virology; 2012 Nov; 433(2):385-94. PubMed ID: 22985477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mSphere of Influence: MmuPV1-a dual tropic papillomavirus, red herring, or novel insight into HPV pathogenesis.
    Romero-Masters J
    mSphere; 2024 Jul; 9(7):e0017724. PubMed ID: 38920397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
    King RE; Rademacher J; Ward-Shaw ET; Hu R; Bilger A; Blaine-Sauer S; Spurgeon ME; Thibeault SL; Lambert PF
    Laryngoscope; 2024 May; 134(5):2322-2330. PubMed ID: 38084790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human papillomavirus 16 E5 gene potentiates MmuPV1-Dependent pathogenesis.
    Torres AD; Spurgeon ME; Bilger A; Blaine-Sauer S; Uberoi A; Buehler D; McGregor SM; Ward-Shaw E; Lambert PF
    Virology; 2020 Feb; 541():1-12. PubMed ID: 31826841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.